Eiger Biopharmaceuticals Inc buy melinda
Start price
07.04.17
/
50%
€8.16
Target price
15.09.17
€9.92
Performance (%)
23.20%
End price
15.09.17
€10.06
Summary
This prediction ended on 15.09.17 with a price of €10.06. The prediction had a final performance of 23.20%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | 3.002% | 4.755% | 23.700% | 68.627% |
| iShares Nasdaq 100 | 2.966% | 0.363% | 8.027% | 116.238% |
| iShares Nikkei 225® | 5.606% | 4.528% | 20.313% | 56.217% |
| iShares S&P 500 | 2.312% | 1.811% | 5.451% | 70.924% |
Comments by melinda for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
Stopped prediction by melinda for Eiger Biopharmaceuticals Inc
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.50
10.02.23
10.02.23
€4.00
10.02.24
10.02.24
-58.40%
31.05.23
31.05.23
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.30
13.03.20
13.03.20
€9.00
04.11.21
04.11.21
28.02%
05.11.21
05.11.21
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€13.30
02.04.19
02.04.19
€14.43
13.03.20
13.03.20
-60.16%
13.03.20
13.03.20
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€9.22
15.10.18
15.10.18
€10.28
17.10.18
17.10.18
13.75%
17.10.18
17.10.18
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€12.36
12.10.17
12.10.17
€13.53
11.01.18
11.01.18
9.49%
11.01.18
11.01.18